AMREP (AXR) News
NYSE: AXRReal EstateHomebuildingUSD
19.91-0.09 (-0.45%)
At close: Nov 20, 3:57 PM ET · Delayed 15 min
AXR news summary
We found 2 recent headlines mentioning AMREP (AXR): 0 in the past week and 2 in the past 30 days, most often from Nasdaq. For price context, AXR is down 0.45% at $19.91. The most recent story, "The Zacks Analyst Blog Highlights Intel, Novartis AG, Itau Unibanco and AMREP", was published by Nasdaq on Oct 27, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest AMREP headlines
- The Zacks Analyst Blog Highlights Intel, Novartis AG, Itau Unibanco and AMREPIntel, Novartis, Itau Unibanco and AMREP face distinct growth opportunities and risks, from AI expansion and drug sales to banking growth and real estate development.NasdaqINTC, NVS, AXR
- Top Analyst Reports for Intel, Novartis & Itau UnibancoIntel's manufacturing recovery and AI expansion, Novartis' growth drugs and Itau Unibanco's strategic moves headline today's top analyst reports.NasdaqINTC, NVS, ROP, KMI